ポル・メド・テック

Kawasaki, JP · 2 known investors

PorMedTec develops transplantable organs and tissues using genetically modified pigs for manufacturing and commercializing as regenerative medicine products. The company targets patients and healthcare systems facing severe organ shortages by providing alternatives to dialysis and other symptom-based treatments.

BiotechHealthtechMedical Devices